Press Release: Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025

Dow Jones
10 Jan

Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025

INDIANAPOLIS--(BUSINESS WIRE)--January 09, 2025-- 

Elevance Health (NYSE: ELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time ("EST"). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

   -- 
 888-947-9963 -- Access Code - 3972058 (Domestic) 
 
 
   -- 
 312-470-0178 -- Access Code - 3972058 (International) 
 
 
   -- 
 866-405-7292 -- No Access Code (Domestic Replay) 
 
 
   -- 
 203-369-0604 -- No Access Code (International Replay) 
 

The replay will be available from 11:30 a.m. EST on January 23, 2025, until the end of the day on February 21, 2025. The call will also be available through a live webcast at www.elevancehealth.com under the "Investors" link. You may also access the webcast here. A webcast replay will be available following the call.

About Elevance Health

Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey -- connecting them to the care, support, and resources they need to lead better lives. Elevance Health's companies serve approximately 113 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250109948306/en/

 
    CONTACT:    Investor Relations: 

Nathan Rich

Investor.Relations@elevancehealth.com

Media Relations:

Leslie Porras

Leslie.Porras@elevancehealth.com

 
 

(END) Dow Jones Newswires

January 09, 2025 16:08 ET (21:08 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10